Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
vivoVerse
Austin, Texas, United Statesvivoverse.com ↗
- Ownership
- Private
- Employees
- ~7
- Development stage
- Other
01
Overview
vivoVerse has developed advanced microfluidic, automation, and AI/ML-enabled platforms—such as the vivoChip and OrganoidChip—for high-throughput in vivo toxicology testing using C. elegans as a model organism. Their solutions enable rapid, cost-effective safety profiling of chemicals with reduced reliance on animal models. The company collaborates with academic labs such as the Ben-Yakar Research Lab at UT Austin to advance organoid-based human-relevant assays for drug development and toxicology applications.
- Therapeutic areas
- NeurologyWomen's HealthOther
- Modalities
- Microfluidic-based screening platformOrgan-on-a-chip technologyOrganism-on-a-chip technology using C. elegans
- Industry
- Non-Drug Biotech
02
Partnerships
Ben-Yakar Research Lab at University of Texas AustinBioTek (for automated imaging integration)Industry partners in pharma/biopharma/agrochemical sectors for pilot projects or collaborations
Beyond the preview
Go deeper on vivoVerse.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on vivoVerse.